These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
999 related items for PubMed ID: 22678056
21. Treatment with an antibody directed against Nogo-A delays disease progression in the SOD1G93A mouse model of Amyotrophic lateral sclerosis. Bros-Facer V, Krull D, Taylor A, Dick JR, Bates SA, Cleveland MS, Prinjha RK, Greensmith L. Hum Mol Genet; 2014 Aug 15; 23(16):4187-200. PubMed ID: 24667415 [Abstract] [Full Text] [Related]
22. Effect of thymic stimulation of CD4+ T cell expansion on disease onset and progression in mutant SOD1 mice. Sheean RK, Weston RH, Perera ND, D'Amico A, Nutt SL, Turner BJ. J Neuroinflammation; 2015 Feb 27; 12():40. PubMed ID: 25889790 [Abstract] [Full Text] [Related]
23. Molecular chaperone mediated late-stage neuroprotection in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis. Novoselov SS, Mustill WJ, Gray AL, Dick JR, Kanuga N, Kalmar B, Greensmith L, Cheetham ME. PLoS One; 2013 Feb 27; 8(8):e73944. PubMed ID: 24023695 [Abstract] [Full Text] [Related]
24. Inhibition of amyloid precursor protein beta-secretase cleavage site affects survival and motor functions of amyotrophic lateral sclerosis transgenic mice. Rabinovich-Toidman P, Becker M, Barbiro B, Solomon B. Neurodegener Dis; 2012 Feb 27; 10(1-4):30-3. PubMed ID: 22269310 [Abstract] [Full Text] [Related]
26. Axonal degeneration, distal collateral branching and neuromuscular junction architecture alterations occur prior to symptom onset in the SOD1(G93A) mouse model of amyotrophic lateral sclerosis. Clark JA, Southam KA, Blizzard CA, King AE, Dickson TC. J Chem Neuroanat; 2016 Oct 27; 76(Pt A):35-47. PubMed ID: 27038603 [Abstract] [Full Text] [Related]
29. Transcriptomic indices of fast and slow disease progression in two mouse models of amyotrophic lateral sclerosis. Nardo G, Iennaco R, Fusi N, Heath PR, Marino M, Trolese MC, Ferraiuolo L, Lawrence N, Shaw PJ, Bendotti C. Brain; 2013 Nov 27; 136(Pt 11):3305-32. PubMed ID: 24065725 [Abstract] [Full Text] [Related]
30. Spinal inhibitory interneuron pathology follows motor neuron degeneration independent of glial mutant superoxide dismutase 1 expression in SOD1-ALS mice. Hossaini M, Cardona Cano S, van Dis V, Haasdijk ED, Hoogenraad CC, Holstege JC, Jaarsma D. J Neuropathol Exp Neurol; 2011 Aug 27; 70(8):662-77. PubMed ID: 21760539 [Abstract] [Full Text] [Related]
31. In vivo quantification of spinal and bulbar motor neuron degeneration in the G93A-SOD1 transgenic mouse model of ALS by T2 relaxation time and apparent diffusion coefficient. Niessen HG, Angenstein F, Sander K, Kunz WS, Teuchert M, Ludolph AC, Heinze HJ, Scheich H, Vielhaber S. Exp Neurol; 2006 Oct 27; 201(2):293-300. PubMed ID: 16740261 [Abstract] [Full Text] [Related]
34. Effects of diet on adenosine monophosphate-activated protein kinase activity and disease progression in an amyotrophic lateral sclerosis model. Zhao Z, Sui Y, Gao W, Cai B, Fan D. J Int Med Res; 2015 Feb 27; 43(1):67-79. PubMed ID: 25534414 [Abstract] [Full Text] [Related]
38. Delayed disease onset and extended survival in the SOD1G93A rat model of amyotrophic lateral sclerosis after suppression of mutant SOD1 in the motor cortex. Thomsen GM, Gowing G, Latter J, Chen M, Vit JP, Staggenborg K, Avalos P, Alkaslasi M, Ferraiuolo L, Likhite S, Kaspar BK, Svendsen CN. J Neurosci; 2014 Nov 19; 34(47):15587-600. PubMed ID: 25411487 [Abstract] [Full Text] [Related]
39. Novel behavioural characteristics of the superoxide dismutase 1 G93A (SOD1G93A ) mouse model of amyotrophic lateral sclerosis include sex-dependent phenotypes. Kreilaus F, Guerra S, Masanetz R, Menne V, Yerbury J, Karl T. Genes Brain Behav; 2020 Feb 19; 19(2):e12604. PubMed ID: 31412164 [Abstract] [Full Text] [Related]